|
TMEM188 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.708200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.938400E-03 |
| Normal-vs-Stage2 |
6.368200E-01 |
| Normal-vs-Stage3 |
6.997400E-01 |
| Normal-vs-Stage4 |
5.366800E-01 |
| Stage1-vs-Stage2 |
1.106980E-01 |
| Stage1-vs-Stage3 |
1.513500E-02 |
| Stage1-vs-Stage4 |
1.336630E-01 |
| Stage2-vs-Stage3 |
8.616200E-01 |
| Stage2-vs-Stage4 |
9.142800E-01 |
| Stage3-vs-Stage4 |
7.583200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.977770E-02 |
| Normal-vs-AfricanAmerican |
9.848200E-01 |
| Normal-vs-Asian |
1.765600E-02 |
| Caucasian-vs-AfricanAmerican |
2.020000E-01 |
| Caucasian-vs-Asian |
2.470000E-01 |
| AfricanAmerican-vs-Asian |
7.930300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.284300E-02 |
| Normal-vs-Female |
4.937800E-02 |
| Male-vs-Female |
8.582200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.881930E-03 |
| Normal-vs-Age(41-60Yrs) |
2.470200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.358200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.301600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.837500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.330400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.775400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.653400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.236600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.976600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.461900E-02 |
| Classical-VS-Follicular |
2.95279999995568E-06 |
| Classical-VS-Other |
6.763200E-01 |
| Classical-VS-Normal |
7.363500E-04 |
| Tall-VS-Follicular |
4.391400E-01 |
| Tall-VS-Other |
5.174400E-01 |
| Tall-VS-Normal |
9.156800E-01 |
| Follicular-VS-Other |
3.118600E-01 |
| Follicular-VS-Normal |
3.395200E-01 |
| Other-VS-Normal |
3.881000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.711200E-01 |
| Normal-vs-N1 |
9.744300E-02 |
| N0-vs-N1 |
3.522600E-01 |
|
|
